Douglas G. Cole

Insider Reports History

Location
Aveo Pharmaceuticals, Inc., 75 Sidney Street, Cambridge, MA
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Douglas G. Cole
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas G. Cole:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. Director Common Stock 26.6K $489K $18.42 Jun 1, 2023 Direct
Foghorn Therapeutics Inc. Director Stock Option (right to buy) 25K $120K $4.79 Jun 17, 2025 Direct
Sana Biotechnology, Inc. Director Stock Option (Right to Buy) 65K Jun 6, 2024 Direct
Denali Therapeutics Inc. Director Stock Option (right to buy) 12.6K Jun 1, 2023 Direct
Sigilon Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $6.64 Aug 11, 2023 Direct

Insider Reports Filed by Douglas G. Cole

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. Jun 17, 2025 1 $120K 4 Jun 17, 2025 Director
FHTX Foghorn Therapeutics Inc. Jun 26, 2024 1 $88.3K 4 Jun 28, 2024 Director
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4/A Jul 15, 2024 Director
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
SGTX Sigilon Therapeutics, Inc. Aug 11, 2023 2 -$7.95K 4 Aug 11, 2023 Director
FHTX Foghorn Therapeutics Inc. Jun 21, 2023 1 $0 4 Jun 22, 2023 Director
SANA Sana Biotechnology, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
DNLI Denali Therapeutics Inc. Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
SGTX Sigilon Therapeutics, Inc. May 19, 2023 1 $0 4 May 22, 2023 Director
FHTX Foghorn Therapeutics Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
SANA Sana Biotechnology, Inc. Jun 6, 2022 1 $0 4 Jun 8, 2022 Director
DNLI Denali Therapeutics Inc. Jun 2, 2022 2 $0 4 Jun 6, 2022 Director
SGTX Sigilon Therapeutics, Inc. May 26, 2022 1 $0 4 May 27, 2022 Director
FHTX Foghorn Therapeutics Inc. Jul 13, 2021 1 $0 4 Jul 14, 2021 Director
SGTX Sigilon Therapeutics, Inc. Jun 24, 2021 1 $88.6K 4 Jun 28, 2021 Director
DNLI Denali Therapeutics Inc. Jun 2, 2021 2 $0 4 Jun 4, 2021 Director
DNLI Denali Therapeutics Inc. Jun 1, 2021 2 $0 4 Jun 3, 2021 Director